FONR Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
FONR is not a good buy right now for a beginner long-term investor with $50,000-$100,000 to deploy. The stock is already trading near resistance in pre-market, is technically overbought, and lacks strong proprietary buy signals. While the latest quarter shows modest growth and the acquisition-related news could create a small near-term catalyst, the overall setup favors waiting rather than buying immediately.
FONR is in a short-term bullish trend, with SMA_5 > SMA_20 > SMA_200, which supports upward momentum. However, the RSI_6 is 88.991, which is extremely overbought and suggests the move has likely run ahead of itself. MACD histogram is positive at 0.0105 but contracting, which points to weakening momentum. The pre-market price of 18.93 is essentially at R1 18.924 and just above the pivot 18.859, so the stock is pressing into resistance rather than offering an attractive entry. Overall trend is positive, but the current entry point is not ideal.
showed revenue growth of 2.39% YoY, net income growth of 4.57% YoY, and EPS growth of 7.41% YoY, indicating steady operating improvement. The news item about FONAR being sold to executives at $19.00 per share for Class B and $6.34 for Class C could act as an event-driven catalyst and may keep attention on the stock. The trading trend data is neutral rather than negative, so there is no strong bearish institutional or insider pressure.
Gross margin fell to 37.95, down 2.77% YoY, which signals some profitability pressure. There are no strong hedge fund or insider buying trends, both are neutral. No recent congress trading data is available. AI Stock Picker shows no signal today and SwingMax shows no recent signal, so there is no proprietary confirmation for an urgent long entry. The stock is also overbought technically, increasing the chance that immediate upside is limited from the current price.
In 2026/Q2, FONAR posted revenue of $25.547M, up 2.39% YoY, net income of $1.924M, up 4.57% YoY, and EPS of $0.29, up 7.41% YoY. This reflects modest but positive growth in the latest quarter. The main weakness is gross margin, which declined to 37.95 from the prior year, suggesting cost pressure or a less favorable mix.
No analyst rating or price target change data was provided. Based on the available information, Wall Street pros would likely see the bull case as modest earnings growth and a possible transaction-related catalyst, while the bear case is limited margin expansion, lack of strong institutional/insider accumulation, and a price that already looks stretched. Overall, there is not enough analyst support in the data to justify an aggressive buy.
